IP finance

"Where money issues meet IP rights". This weblog looks at financial issues for intellectual property rights: securitisation and collateral, IP valuation for acquisition and balance sheet purposes, tax and R&D breaks, film and product finance, calculating quantum of damages--anything that happens where IP meets money.

Showing posts with label biden. Show all posts
Showing posts with label biden. Show all posts
Sunday, 9 May 2021

It is simplistic and short-sighted to undermine Covid-19 patent rights

›
President Biden’s administration is making a major mistake by its top trade advisor, Katherine Tai, advocating a waiver of patent rights for...
Tuesday, 1 September 2020

Trump to Push Pharma on Drug Pricing

›
President Trump is continuing his push to fulfill campaign promises.  Apparently, he is meeting with pharmaceutical companies this week to ...
Monday, 6 July 2020

Where will the Great Brand Odwalla Land?

›
In a past post, I wrote about how great brands and products never die .  I provided two examples: the first, was Sesame Street; and the s...
Saturday, 21 March 2020

Is it Time to Increase Funding to Universities for Research and Development in the United States?

›
In a document released by the Association of American Universities (AAU), Mary Sue Coleman, president of the organization, discusses Vannev...
›
Home
View web version
Powered by Blogger.